Arotinolol
Arotinolol (INN, marketed under the tradename Almarl) is a medication in the class of mixed alpha/beta blockers. It also acts as a β3 receptor agonist. A 1979 publication suggests arotinolol as having first been described in the scientific literature by Sumitomo Chemical as "β-adrenergic blocking, antiarrhythmic compound S-596".
Wikipage redirect
primaryTopic
Arotinolol
Arotinolol (INN, marketed under the tradename Almarl) is a medication in the class of mixed alpha/beta blockers. It also acts as a β3 receptor agonist. A 1979 publication suggests arotinolol as having first been described in the scientific literature by Sumitomo Chemical as "β-adrenergic blocking, antiarrhythmic compound S-596".
has abstract
Arotinolol (INN, marketed unde ...... ntiarrhythmic compound S-596".
@en
ATC prefix
Bioavailability
CAS number
41287-43-8
FDA UNII code
394E3P3B99
IUPAC name
(RS)-5-(2-{[3-(tert-butylamino ...... l-4-yl)thiophene-2-carboxamide
@en
PubChem
thumbnail
Link from a Wikipage to an external page
Wikipage page ID
18,606,379
Wikipage revision ID
744,956,906
ChEMBL
ChemSpiderID
elimination half-life
legal status
molecular weight
routes of administration
StdInChIKey
BHIAIPWSVYSKJS-UHFFFAOYSA-N
Verifiedfields
verifiedrevid
457,153,102
hypernym
comment
Arotinolol (INN, marketed unde ...... ntiarrhythmic compound S-596".
@en
label
Arotinolol
@en
